ILMN

$267.76 -1.27% $-3.45
Oct 7, 2026 04:00 AM

ILMN stands for Illumina, Inc., a company specializing in genetic sequencing and genomics.

Scroll or pinch to zoom · drag to pan the chart

Updating chart…

Price chart bar size:

Share on:

Asset Summary

Loading summary…

Asset Performance Metrics and Risk Characteristics:

Metrics below use daily returns for Jan 1, 2026 – Oct 7, 2026 (YTD).

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. Using indicators such as moving averages, pivot levels, momentum studies, and candlestick pattern scans can clarify trend strength and volatility. The tabs below summarize moving averages, pivots, technical indicators, candlestick patterns, and recent prices for this symbol.

Analysis

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Advance Your ILMN Trading Now

Take control of your trading with OHLCX Platform. Our platform offers unparalleled analysis and technical support for ILMN, designed to enhance your market performance. Start optimizing your trades today and experience the difference with our expert tools!

Boost Performance Now

Frequently Asked Questions

Yes, Illumina invests heavily in R&D to drive innovation in genomics and improve sequencing platforms.

Illumina was founded in 1998 and has since become a leader in DNA sequencing technology.

Illumina’s technologies enable researchers and clinicians to tailor treatments based on individual genetic profiles.

Illumina supports healthcare advancements by providing tools that facilitate genomic research and diagnostics.

Illumina is headquartered in San Diego, California, USA.

Illumina partners with various organizations, including research institutions and healthcare providers, to advance genomic research.

Illumina’s technology accelerates research in genetics, enabling breakthroughs in understanding diseases and treatments.

Illumina is a market leader in the genomics space, widely recognized for its innovation and extensive product range.

Investors can visit Illumina’s official website to access investor relations information and financial reports.

Illumina’s primary products are DNA sequencing machines and reagents used in genomic analysis.

Enhance Your ILMN Trading Now

Experience the future of trading with OHLCX execution platform. Our advanced system delivers in-depth analysis and insights for ILMN, utilizing state-of-the-art technical tools and strategies. Enhance your market performance today and see how we can elevate your trading results!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.